Genetically engineered live attenuated influenza A virus vaccine candidates

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2772-2778

  Parkin, Neil T ^a,b   Chiu, Peggy ^a   Coelingh, Kathleen ^a  

^a MEDIMMUNE   (United States)

^b MONOGRAM BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; FERRET; GENETIC ENGINEERING; GENETIC STABILITY; INFECTION PREVENTION; INFLUENZA VIRUS A; INTRANASAL DRUG ADMINISTRATION; KIDNEY CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0030937733     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2772-2778.1997     Document Type: Article

References (53)

1. Altmann, M., I. Edery, H. Trachsel, and N. Sonenberg. 1988. Site-directed mutagenesis of the tryptophan residues in yeast eukaryotic initiation factor 4E. J. Biol. Chem. 263:17229-17232.
2. Barrett, T., and S. C. Inglis. 1985. Growth, purification and titration of influenza viruses, p. 119-150. In B. W. J. Mahy (ed.), Virology: a practical approach. IRL Press, Oxford, England.
3. Biswas, S. K., and D. P. Nayak. 1996. Influenza virus polymerase basic protein 1 interacts with influenza virus polymerase basic protein 2 at multiple sites. J. Virol. 70:6716-6722.
4. Braam, J., I. Ulmanen, and R. M. Krug. 1983. Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Cell 34:609-618.
5. Clements, M. L., E. K. Subbarao, L. F. Fries, R. A. Karron, W. T. London, and B. R. Murphy. 1992. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J. Clin. Microbiol. 30:655-662.
6. Cox, N. J., F. Kitame, A. P. Kendal, H. F. Maassab, and C. Naeve. 1988. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology 167:554-567.
7. de la Luna, S., C. Martinez, and J. Ortin. 1989. Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res. 13:143-155.
8. Detjen, B. M., C. St. Angelo, M. G. Katze, and R. M. Krug. 1987. The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J. Virol. 61:16-22.
9. Fazekas, G., B. Rosenwirth, P. Dukor, J. Gergely, and E. Rajnavolgyi. 1994. IgG isotype distribution of local and systemic immune responses induced by influenza virus infection. Eur. J. Immunol. 24:3063-3067.
10. Fedson, D. S. 1994. Influenza and pneumococcal vaccination of the elderly: newer vaccines and prospects for clinical benefits at the margin. Prev. Med. 23:751-755.
11. Foster, D. A., A. Talsma, A. Furumoto-Dawson. S. E. Ohmit, J. R. Margulies, N. H. Arden, and A. S. Monto. 1992. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am. J. Epidemiol. 136:296-307.
12. Glezen, W. P. 1982. Serious morbidity and mortality associated with influenza epidemics. Epidemiol. Rev. 4:25-44.
13. Glezen, W. P., A. A. Payne, D. N. Snyder, and T. D. Downs. 1982. Mortality and influenza. J. Infect. Dis. 146:313-321.
14. Gorse, G. J., and R. B. Belshe. 1990. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults. J. Clin. Microbiol. 28:2539-2550.
15. Gorse, G. J., R. B. Belshe, and N. J. Munn. 1988. Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccine. J. Clin. Microbiol. 26:911-918.
16. Gorse, G. J., R. B. Belshe, and N. J. Munn. 1991. Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults. Chest 100:977-984.
17. Gorse, G. J., E. E. Otto, D. C. Powers, G. W. Chambers, C. S. Eickhoff, and F. K. Newman. 1996. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J. Infect. Dis. 173:285-290.
18. Govaert, T. M., C. T. Thijs, N. Masurel, M. J. Sprenger, G. J. Dinant, and J. A. Knottnerus. 1994. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272: 1661-1665.
19. Herlocher, M. L., D. C. DeBorde, M. W. Shaw, and H. F. Maassab. 1989. Origin of ft phenotype expression of cold-adapted influenza virus A/AA/6/60, p. 387-401. In D. Kolakofsky and B. Mahy (ed.), Genetics and pathogenicity of negative strand viruses. Elsevier Biomedical Press, Amsterdam, The Netherlands.
20. Herlocher, M. L., H. F. Maassab, and R. G. Webster. 1993. Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus. Proc. Natl. Acad. Sci. USA 90:6032-6036.
21. Ishida, T., M. Katsuta, M. Inoue, Y. Yamagata, and K.-I. Tomita. 1983. The stacking interactions in 7-methylguanine-tryptophan systems, a model study for the interaction between the "cap" structure of mRNA and its binding protein. Biochem. Biophys. Res. Commun. 115:849-854.
22. Kilbourne, E. D. 1993. Inactivated influenza vaccines, p. 565-581. In S. A. Plotkin and E. A. Mortimer (ed.). Vaccines. The W. B. Saunders Co., Philadelphia, Pa.
23. Lawson, C. M., E. K. Subbarao, and B. R. Murphy. 1992. Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus. Virology 191:506-510. (Erratum, 145:302, 1993.)
24. Maassab, H. F. 1959. The propagation of multiple viruses in chick kidney cultures. Proc. Natl. Acad. Sci. USA 45:1035-1039.
25. Maassab, H. F., A. P. Kendal, G. D. Abrams, and A. S. Monto. 1982. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J. Infect. Dis. 146:780-790.
26. Maassab, H. F. Personal communication.
27. Maassab, H. F., M. W. Shaw, and C. A. Heilman. 1993. Live influenza virus vaccine, p. 781-801. In S. A. Plotkin and E. A. Mortimer (ed.), Vaccines. The W. B. Saunders Co., Philadelphia, Pa.
28. Massicot, J. G., B. R. Murphy, F. Thierry, L. Markoff, K. Y. Huang, and R. M. Chanock. 1980. Temperature-sensitive mutants of influenza virus. Identification of the loci of the two ts lesions in the Udorn-ts-1A2 donor virus and the correlation of the presence of these two ts lesions with a predictable level of attenuation. Virology 101:242-249.
29. Massicot. J. G., B. R. Murphy, K. van Wyke, K. Y. Huang, and R. M. Chanock. 1980. ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus. Virology 106:187-190.
30. McCauley, J. W., and C. R. Penn. 1990. The critical cut-off temperature of avian influenza viruses. Virus Res. 17:191-198.
31. Mukaigawa, J., and D. P. Nayak. 1991. Two signals mediate nuclear localization of influenza virus (A/WSN/33) polymerase basic protein 2. J. Virol. 65:245-253.
32. Murphy, B. R., and R. M. Chanock. 1981. Genetic approaches to the prevention of influenza A virus infection, p. 601-615. In D. P. Nayak (ed.), Genetic variation among influenza viruses. Academic Press, Inc., New York, N.Y.
33. Murphy, B. R., L. J. Markoff, R. M. Chanock, S. B. Spring, H. F. Maassab, A. P. Kendal, N. J. Cox, M. M. Levine, R. G. Douglas, Jr., R. F. Betts, R. B. Couch, and T. R. Cate, Jr. 1980. Genetic approaches to attenuation of influenza A viruses for man. Philos. Trans. R. Soc. London Ser. B 288:401-415.
34. Murphy, B. R., L. J. Markoff, N. T. Hosier, J. G. Massicot, and R. M. Chanock. 1982. Production and level of genetic stability of an influenza A virus temperature-sensitive mutant containing two genes with ts mutations. Infect. Immun. 37:235-242.
35. Murphy, B. R., M. D. Tolpin, J. G. Massicot, H. Y. Kim, R. H. Parrott, and R. M. Chanock. 1980. Escape of a highly defective influenza A virus mutant from its temperature sensitive phenotype by extragenic suppression and other types of mutation. Ann. N.Y. Acad. Sci. 354:172-182.
36. Nichol, K. L., K. L. Margolis, J. Wuorenma, and T. Von Sternberg. 1994. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 331:778-784.
37. Parkin, N. T., P. Chiu, and K. L. Coelingh. 1996. Temperature sensitive mutants of influenza A virus generated by reverse genetics and clustered charged to alaninc mutagenesis. Virus Res. 46:31-44.
38. Patriarca, P. A., J. A. Weber, R. A. Parker, W. N. Hall, A. P. Kendal, D. J. Bregman, and L. B. Schonberger. 1985. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 253:1136-1139.
39. 7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23:847-853.
40. Powers, D. C., L. F. Fries, B. R. Murphy, B. Thumar, and M. L. Clements. 1991. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory. J. Clin. Microbiol. 29:498-505.
41. Powers, D. C., B. R. Murphy, L. F. Fries, W. H. Adler, and M. L. Clements. 1992. Reduced intectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies. J. Am. Geriatr. Soc. 40:163-167.
42. Shi, L., D. F. Summers, Q. Peng, and J. M. Galarza. 1995. Influenza A virus RNA polymerasc subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme. Virology 208:38-47.
43. Smith, H., and C. Sweet. 1988. Lessons for human influenza from pathogenicity studies with ferrets. Rev. Infect. Dis. 10:56-75.
44. Snyder, M. H., R. F. Betts, D. DeBorde, E. L. Tierney, M. L. Clements, D. Herrington, S. D. Sears, R. Dolin, H. F. Maassab, and B. R. Murphy. 1988. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J. Virol. 62:488-495.
45. St. Angelo, C., G. E. Smith, M. D. Summers, and R. M. Krug. 1987. Two of the three influenza viral polymerase proteins expressed by using baculovirus vectors form a complex in insect cells. J. Virol. 61:361-365.
46. Subbarao, E. K., Y. Kawaoka, and B. R. Murphy. 1993. Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation. J. Virol. 67: 7223-7228.
47. Subbarao, E. K., E. J. Park, C. M. Lawson, A. Y. Chen, and B. R. Murphy. 1995. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. J. Virol. 69:5969-5977.
48. Tolpin, M. U., M. L. Clements, M. M. Levine, R. E. Black, A. J. Saah, W. C. Anthony, L. Cisneros, R. M. Chanock, and B. R. Murphy. 1982. Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses. Infect. Immun. 36:645-650.
49. Tolpin, M. D., J. G. Massicot, M. G. Mullinix, H. W. Kim, R. H. Parrott, R. M. Chanock, and B. R. Murphy. 1981. Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo. Virology 112:505-517.
50. Treanor, J., M. Perkins, R. Battaglia, and B. R. Murphy. 1994. Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus. J. Virol. 68:7684-7688.
51. 7GpppNm) on RNAs and in initiating viral RNA transcription. Proc. Natl. Acad. Sci. USA 78: 7355-7359.
52. Wright, P. F., S. H. Sell, T. Shinozaki, J. Thompson, and D. T. Karzon. 1975. Safety and antigenicity of influenza A/Hong Kong/68-ts-1 [E] (H3N2) vaccine in young seronegative children. J. Pediatr. 87:1109-1116.
53. Yamanaka, K., N. Ogasawara, M. Ueda, H. Yoshikawa, A. Ishihama, and K. Nagata. 1990. Characterization of a temperature-sensitive mutant in the RNA polymerase PB2 subunit gene of influenza A/WSN/33 virus. Arch. Virol. 114:65-73.